Jubilant Pharmova receives four FDA observations at India facility

The USFDA completed a pre-approval inspection of Jubilant Pharmova Limited's solid dosage manufacturing facility in Roorkee, India, resulting in four observations.

The company plans to submit an action plan to address the observations. The facility generates less than one percent of Jubilant Pharmova's total revenues.